A61K 31/7012
Compounds having a free or esterified carboxyl group attached, directly or through
Official title: Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K31/191; ascorbic acid A61K31/375)
A61K31/7012 (Compounds having a free or esterified carboxyl group attached, directly or through) appears on 255 US grants and 420 published applications in this corpus.
Search patents in A61K- Granted patents
- 255
- Published applications
- 420
- Assignees
- 260
- Inventors
- 877
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 30 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 2 |
| 2003 | 4 | 20 |
| 2004 | 3 | 18 |
| 2005 | 7 | 14 |
| 2006 | 5 | 29 |
| 2007 | 9 | 22 |
| 2008 | 4 | 7 |
| 2009 | 8 | 14 |
| 2010 | 7 | 21 |
| 2011 | 7 | 11 |
| 2012 | 4 | 10 |
| 2013 | 11 | 16 |
| 2014 | 14 | 26 |
| 2015 | 11 | 16 |
| 2016 | 17 | 18 |
| 2017 | 12 | 19 |
| 2018 | 6 | 16 |
| 2019 | 11 | 21 |
| 2020 | 9 | 17 |
| 2021 | 13 | 25 |
| 2022 | 12 | 22 |
| 2023 | 9 | 16 |
| 2024 | 5 | 18 |
| 2025 | 7 | 11 |
| 2026 | 8 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of treating viral infections with hexose type monosaccharides and analogs thereof15 Sep 2026US 12,734,185 B2Board of Regents, The University of Texas System
- Immunogenic compositions containing N-glycolylneuraminic acid bearing nanoparticles18 Aug 2026US 12,708,637 B2Ramot at Tel-Aviv University Ltd.
- N-acetylneuraminic acid compositions and methods of use21 Jul 2026US 12,685,741 B2LifeScience AS
- Therapeutics for treatment of COVID-19 symptoms30 Jun 2026US 12,667,581 B2The Texas A&M University System
- Antiviral compositions for treating the flu7 Apr 2026US 12,594,280 B2Hospices Civils De Lyon
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- N-derivatized sialic acids and related sialosides20 Aug 2026US 2026/0242405 A1The Regents of the University of California
- Mannuronate, guluronate and gulumannuronate topical gel or cream and method for its preparation30 Jul 2026US 2026/0216056 A1Floating Knight Biotech Pte. Ltd.
- Methods of treating insulin resistance and associated disorders25 Jun 2026US 2026/0174677 A1The University of Melboune
- Composition for preventing and/or improving brain dysfunction25 Jun 2026US 2026/0174724 A1The Institute of Bioactive Peptides
Most cited
By later US patents
- Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients174US 6,077,543 AInhale Therapeutic Systems · 2000
- Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof163US 6,001,336 AInhale Therapeutic Systems · 1999
- Processes for spray drying hydrophobic drugs in organic solvent suspensions158US 5,976,574 AInhale Therapeutic Systems · 1999
- Processes for spray drying solutions of hydrophobic drugs and compositions thereof122US 5,985,248 AInhale Therapeutic Systems · 1999
- Method of using hydroxycarboxylic acids or related compounds for treating skin changes associated with intrinsic and extrinsic aging97US 6,767,924 B2Tristrata Technology, Inc. · 2004